SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $678,590 | -70.5% | 5,598 | -72.2% | 0.09% | -68.8% |
| Q2 2023 | $2,303,386 | -2.2% | 20,113 | +17.8% | 0.28% | -7.0% |
| Q1 2023 | $2,354,263 | +28.5% | 17,081 | +20.8% | 0.30% | +27.1% |
| Q4 2022 | $1,832,780 | +789.7% | 14,144 | +657.6% | 0.24% | +713.8% |
| Q3 2022 | $206,000 | -1.9% | 1,867 | -33.3% | 0.03% | +3.6% |
| Q2 2022 | $210,000 | -10.3% | 2,800 | -6.7% | 0.03% | +3.7% |
| Q1 2022 | $234,000 | -6.0% | 3,001 | +8.4% | 0.03% | -6.9% |
| Q4 2021 | $249,000 | +4.6% | 2,769 | +7.6% | 0.03% | -3.3% |
| Q3 2021 | $238,000 | +296.7% | 2,574 | +137.9% | 0.03% | -41.2% |
| Q4 2017 | $60,000 | – | 1,082 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |